Logo image of IMCD.AS

IMCD NV (IMCD.AS) Stock Fundamental Analysis

AMS:IMCD - Euronext Amsterdam - NL0010801007 - Common Stock - Currency: EUR

137.4  +0.85 (+0.62%)

Fundamental Rating

5

Overall IMCD gets a fundamental rating of 5 out of 10. We evaluated IMCD against 16 industry peers in the Trading Companies & Distributors industry. IMCD has an excellent profitability rating, but there are some minor concerns on its financial health. IMCD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

IMCD had positive earnings in the past year.
In the past year IMCD had a positive cash flow from operations.
IMCD had positive earnings in each of the past 5 years.
IMCD had a positive operating cash flow in each of the past 5 years.
IMCD.AS Yearly Net Income VS EBIT VS OCF VS FCFIMCD.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

IMCD has a Return On Assets of 5.70%. This is amongst the best in the industry. IMCD outperforms 81.25% of its industry peers.
With a decent Return On Equity value of 12.57%, IMCD is doing good in the industry, outperforming 68.75% of the companies in the same industry.
IMCD has a Return On Invested Capital of 8.08%. This is in the better half of the industry: IMCD outperforms 68.75% of its industry peers.
IMCD had an Average Return On Invested Capital over the past 3 years of 9.57%. This is in line with the industry average of 8.56%.
Industry RankSector Rank
ROA 5.7%
ROE 12.57%
ROIC 8.08%
ROA(3y)7.11%
ROA(5y)6.42%
ROE(3y)16.08%
ROE(5y)14.41%
ROIC(3y)9.57%
ROIC(5y)8.66%
IMCD.AS Yearly ROA, ROE, ROICIMCD.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of IMCD (5.89%) is better than 93.75% of its industry peers.
In the last couple of years the Profit Margin of IMCD has grown nicely.
Looking at the Operating Margin, with a value of 8.99%, IMCD belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
IMCD's Operating Margin has improved in the last couple of years.
IMCD's Gross Margin of 22.49% is fine compared to the rest of the industry. IMCD outperforms 68.75% of its industry peers.
In the last couple of years the Gross Margin of IMCD has grown nicely.
Industry RankSector Rank
OM 8.99%
PM (TTM) 5.89%
GM 22.49%
OM growth 3Y0.9%
OM growth 5Y6.54%
PM growth 3Y-0.83%
PM growth 5Y7.95%
GM growth 3Y1.7%
GM growth 5Y2.81%
IMCD.AS Yearly Profit, Operating, Gross MarginsIMCD.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IMCD is still creating some value.
IMCD has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, IMCD has more shares outstanding
IMCD has a better debt/assets ratio than last year.
IMCD.AS Yearly Shares OutstandingIMCD.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
IMCD.AS Yearly Total Debt VS Total AssetsIMCD.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 3.60 indicates that IMCD is not in any danger for bankruptcy at the moment.
IMCD has a better Altman-Z score (3.60) than 68.75% of its industry peers.
The Debt to FCF ratio of IMCD is 7.15, which is on the high side as it means it would take IMCD, 7.15 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 7.15, IMCD is doing good in the industry, outperforming 68.75% of the companies in the same industry.
A Debt/Equity ratio of 0.63 indicates that IMCD is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.63, IMCD is in line with its industry, outperforming 43.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 7.15
Altman-Z 3.6
ROIC/WACC1.21
WACC6.68%
IMCD.AS Yearly LT Debt VS Equity VS FCFIMCD.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

IMCD has a Current Ratio of 1.98. This is a normal value and indicates that IMCD is financially healthy and should not expect problems in meeting its short term obligations.
IMCD has a Current ratio (1.98) which is comparable to the rest of the industry.
A Quick Ratio of 1.29 indicates that IMCD should not have too much problems paying its short term obligations.
IMCD has a better Quick ratio (1.29) than 68.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.98
Quick Ratio 1.29
IMCD.AS Yearly Current Assets VS Current LiabilitesIMCD.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

IMCD shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.28%.
Measured over the past years, IMCD shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.74% on average per year.
The Revenue has been growing slightly by 6.41% in the past year.
The Revenue has been growing by 11.94% on average over the past years. This is quite good.
EPS 1Y (TTM)-5.28%
EPS 3Y10.14%
EPS 5Y18.74%
EPS Q2Q%-2.82%
Revenue 1Y (TTM)6.41%
Revenue growth 3Y11.23%
Revenue growth 5Y11.94%
Sales Q2Q%120.28%

3.2 Future

IMCD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.90% yearly.
The Revenue is expected to grow by 7.61% on average over the next years.
EPS Next Y9.9%
EPS Next 2Y9.94%
EPS Next 3Y9.28%
EPS Next 5Y8.9%
Revenue Next Year7.45%
Revenue Next 2Y6.66%
Revenue Next 3Y5.07%
Revenue Next 5Y7.61%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IMCD.AS Yearly Revenue VS EstimatesIMCD.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2032 2B 4B 6B
IMCD.AS Yearly EPS VS EstimatesIMCD.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2032 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 28.27 indicates a quite expensive valuation of IMCD.
IMCD's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of IMCD to the average of the S&P500 Index (29.35), we can say IMCD is valued inline with the index average.
A Price/Forward Earnings ratio of 20.46 indicates a rather expensive valuation of IMCD.
IMCD's Price/Forward Earnings ratio is in line with the industry average.
IMCD is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.27
Fwd PE 20.46
IMCD.AS Price Earnings VS Forward Price EarningsIMCD.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as IMCD.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IMCD is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 32.13
EV/EBITDA 16.74
IMCD.AS Per share dataIMCD.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of IMCD may justify a higher PE ratio.
PEG (NY)2.85
PEG (5Y)1.51
EPS Next 2Y9.94%
EPS Next 3Y9.28%

3

5. Dividend

5.1 Amount

IMCD has a Yearly Dividend Yield of 1.57%. Purely for dividend investing, there may be better candidates out there.
IMCD's Dividend Yield is comparable with the industry average which is at 2.53.
IMCD's Dividend Yield is slightly below the S&P500 average, which is at 2.33.
Industry RankSector Rank
Dividend Yield 1.57%

5.2 History

On average, the dividend of IMCD grows each year by 22.38%, which is quite nice.
Dividend Growth(5Y)22.38%
Div Incr Years1
Div Non Decr Years1
IMCD.AS Yearly Dividends per shareIMCD.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

45.88% of the earnings are spent on dividend by IMCD. This is a bit on the high side, but may be sustainable.
The dividend of IMCD is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP45.88%
EPS Next 2Y9.94%
EPS Next 3Y9.28%
IMCD.AS Yearly Income VS Free CF VS DividendIMCD.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
IMCD.AS Dividend Payout.IMCD.AS Dividend Payout, showing the Payout Ratio.IMCD.AS Dividend Payout.PayoutRetained Earnings

IMCD NV

AMS:IMCD (3/7/2025, 7:00:00 PM)

137.4

+0.85 (+0.62%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)03-05 2025-03-05/amc
Earnings (Next)04-25 2025-04-25
Inst Owners75.23%
Inst Owner ChangeN/A
Ins Owners1.7%
Ins Owner ChangeN/A
Market Cap8.12B
Analysts77.39
Price Target167.76 (22.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.57%
Yearly Dividend2.2
Dividend Growth(5Y)22.38%
DP45.88%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)50.02%
Min Revenue beat(2)-1.07%
Max Revenue beat(2)101.12%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.86%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.8%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)1.46%
Valuation
Industry RankSector Rank
PE 28.27
Fwd PE 20.46
P/S 1.72
P/FCF 32.13
P/OCF 29.09
P/B 3.67
P/tB N/A
EV/EBITDA 16.74
EPS(TTM)4.86
EY3.54%
EPS(NY)6.71
Fwd EY4.89%
FCF(TTM)4.28
FCFY3.11%
OCF(TTM)4.72
OCFY3.44%
SpS79.98
BVpS37.45
TBVpS-6.68
PEG (NY)2.85
PEG (5Y)1.51
Profitability
Industry RankSector Rank
ROA 5.7%
ROE 12.57%
ROCE 11.09%
ROIC 8.08%
ROICexc 9.36%
ROICexgc 44.32%
OM 8.99%
PM (TTM) 5.89%
GM 22.49%
FCFM 5.35%
ROA(3y)7.11%
ROA(5y)6.42%
ROE(3y)16.08%
ROE(5y)14.41%
ROIC(3y)9.57%
ROIC(5y)8.66%
ROICexc(3y)10.67%
ROICexc(5y)9.54%
ROICexgc(3y)40.09%
ROICexgc(5y)35.52%
ROCE(3y)14.12%
ROCE(5y)13.14%
ROICexcg growth 3Y11.47%
ROICexcg growth 5Y12.83%
ROICexc growth 3Y2.19%
ROICexc growth 5Y4.08%
OM growth 3Y0.9%
OM growth 5Y6.54%
PM growth 3Y-0.83%
PM growth 5Y7.95%
GM growth 3Y1.7%
GM growth 5Y2.81%
F-Score5
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 7.15
Debt/EBITDA 2.49
Cap/Depr 19.36%
Cap/Sales 0.56%
Interest Coverage 6.94
Cash Conversion 49.71%
Profit Quality 90.84%
Current Ratio 1.98
Quick Ratio 1.29
Altman-Z 3.6
F-Score5
WACC6.68%
ROIC/WACC1.21
Cap/Depr(3y)23.75%
Cap/Depr(5y)23.21%
Cap/Sales(3y)0.62%
Cap/Sales(5y)0.61%
Profit Quality(3y)103.46%
Profit Quality(5y)114.83%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.28%
EPS 3Y10.14%
EPS 5Y18.74%
EPS Q2Q%-2.82%
EPS Next Y9.9%
EPS Next 2Y9.94%
EPS Next 3Y9.28%
EPS Next 5Y8.9%
Revenue 1Y (TTM)6.41%
Revenue growth 3Y11.23%
Revenue growth 5Y11.94%
Sales Q2Q%120.28%
Revenue Next Year7.45%
Revenue Next 2Y6.66%
Revenue Next 3Y5.07%
Revenue Next 5Y7.61%
EBIT growth 1Y-0.8%
EBIT growth 3Y12.24%
EBIT growth 5Y19.26%
EBIT Next Year30.36%
EBIT Next 3Y15.18%
EBIT Next 5YN/A
FCF growth 1Y-33.93%
FCF growth 3Y12.49%
FCF growth 5Y10.07%
OCF growth 1Y-33.52%
OCF growth 3Y12.47%
OCF growth 5Y9.9%